Back to search
FDAFDA · Food and drugs·Recall number D-0012-2025

Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87.

Published October 23, 2024 · Recall initiated: September 17, 2024

Summary

FDA records drug Class I recall D-0012-2025, published October 23, 2024 and initiated September 17, 2024. Recalling firm: Bionpharma Inc.; Status: Terminated; Reported quantity: 1,980 bottles; Lot: Lot # 2310083, Exp. 09/30/2025. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

What to do

Voluntary: Firm initiated · Press Release

Get an email if ATOVAQUONE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATOVAQUONE
Manufacturer
Bionpharma Inc.
Distributor
Nationwide in the U.S.A.
UPC
0369452252871
Lot
Lot # 2310083, Exp. 09/30/2025
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atovaquone Oral Suspension, USP 750 mg/5 mL, 210 mL bottle, Rx only, Distributed by: Bionpharma Inc., Princeton, NJ 08540, NDC # 69452-252-87. recalled?

Yes. FDA published recall D-0012-2025 on October 23, 2024. Reported hazard: Microbial Contamination of a Non-sterile Product: The product was found to be contaminated with Cohnella bacteria.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATOVAQUONE. UPC: 0369452252871.